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Background: Glucokinase (GK) is a metabolic enzyme encoded by the GCK gene and expressed in glucose-sensitive
tissues, principally pancreatic islets cell and hepatocytes. The GK protein acts in pancreatic islets as a “glucose sensor”
that couples fluctuations in the blood glucose concentration to changes in cellular function and insulin secretion.
GCK and GK have proposed importance in the development and progression of diabetes mellitus and are potential
therapeutic targets for diabetes treatment. The study was undertaken to determine the nucleotide sequence of
feline pancreatic GK cDNA, predict the amino acid sequence and structure of the feline GK protein, and perform
comparative bioinformatic analysis of feline cDNA and protein. Routine PCR techniques were used with cDNA from
feline pancreas. Clones were assembled to obtain the full length cDNA. Protein prediction and modeling were
performed using bioinformatic tools.
Results: Full-length feline pancreatic GK cDNA contains a 1398 nucleotide coding sequence with high identity to
other pancreatic GK cDNAs. The deduced 465 amino acid feline protein has 15 amino acid substitutions not found
in other mammalian GK proteins but maintains high structural homology with human GK. Feline pancreatic GK is
highly conserved at nucleotide and protein levels. Residues crucial for substrate binding and catalysis are
completely conserved in the feline protein.
Conclusion: Molecular analysis predicts that feline pancreatic GK functions similarly to other mammalian GK
proteins.
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Glucokinase (GK) is a metabolic enzyme encoded by the
GCK gene and expressed in glucose-sensitive tissues,
principally pancreatic islets cell and hepatocytes. Pancre-
atic and hepatic GK enzymes are isoforms that differ
slightly in the N-terminus amino acid sequence [1]. The
isoforms arise from tissue-specific mRNAs that are
encoded by a single GCK gene under control of separate
promoters [1]. In pancreas and liver, the GK protein func-
tions as a “glucose sensor” that couples fluctuations in the
blood glucose concentration to changes in cellular func-
tion. Biochemical analysis has determined that the
metabolic control strength of pancreatic GK for glucose
metabolism is near unity, a finding supported by results* Correspondence: tscherme@vet.ksu.edu
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article, unless otherwise stated.of gene expression studies that shows that the GCK gene
exerts a dose dependent effect on glucose metabolism [2].
Knowledge about feline GK and its metabolic role is
incomplete. The domestic cat (Felis catus) is an obligate
carnivore and must have evolved specialized mecha-
nisms suited for consumption of a diet containing large
amounts of protein but relatively little carbohydrate
(reviewed by [3]). Several early studies reported reduced
or absent activity of the GK enzyme and its regulatory
protein (GKRP) in feline liver when compared with
other species [4,5]. Recent studies have shown that the
feline liver does not express mRNA for GK [5] or GKRP
[6], which suggests that reduced expression of genes in-
volved in glucose-sensing is responsible for the low GK
enzyme activity observed in early studies. Although GK
mRNA expression has been documented in the feline
pancreas [5,7], expression and activity of the feline pan-
creatic GK isoform has not been studied in depth. Givened Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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insulin-producing islet cells and the requirement for GK
in normal glucose metabolism and insulin secretion,
detailed knowledge about GK expression and function may
improve understanding of feline carbohydrate metabolism.
The objective of the current study was to characterize
the feline pancreatic GK isoform and compare the feline
isoform with GK from non-carnivorous mammals. Study
aims were to determine the nucleotide sequence of pan-
creatic GCK cDNA, predict the amino acid sequence and
structure of the feline GK protein, and perform bioinfor-
matic analysis of the feline cDNA and protein.
Results and Discussion
Feline GK cDNA coding sequence and alignments
Structural features of the complete feline pancreatic GK
cDNA are shown in Figure 1. Alignment of DNA clones
yielded a 2513 bp cDNA sequence with 9 putative ORFs.
An ORF beginning at base 140 of the cDNA sequence
spanned 1398 bp and represented the complete feline
GK CDS. Nucleotide identities between the feline CDS
and sequences from human, chimpanzee, rat, and mouse
were 92%, 92%, 87%, and 88%, respectively. Using the
known exonic structure of human GK mRNA (Genbank
accession NM_000162), it was determined that feline
GK contains 10 exons. RACE cloning yielded sequence
information for putative 5’and 3’ UTRs contained in the
feline GK mRNA. The 5’-UTR contained a 139 bp
sequence located immediately upstream to the ORF that
encodes the 1398 bp CDS. The 976 bp immediately
following the CDS stop codon comprises the 3’-UTR.
Additional alignments were carried out using the fGK
cDNA sequence and the feline genomic sequence (Felis_-
catus-6.2 reference assembly). Since the linear cDNA
contains only exon information the alignment was limited
to coding regions of the feline GK gene. The 5’-UTR and
exon 1 of fGK cDNA had 100% identity with a short
184 nt genomic sequence located approximately 32 kb
upstream from the start of exon 2. Overall, nt identity
between fGK exons 2–10 and the 3’-UTR, excludingFigure 1 Schematic representation of the feline pancreatic GK cDNA.
blocks. The coding region is divided into 10 exons, which are represented
The position of DNA clones produced by each primer set used in PCR reac
accession EF121813).intervening intron sequences, was 99.8%. Three A/G
nucleotide differences were detected in the 3’-UTR
sequences. A T/C change at position 119 in exon 9 was
the only non-identity in a coding region.
Predicted feline pancreatic GK protein sequence,
alignments and bioinformatic analysis
The feline pancreatic GK protein deduced from the
1398 bp CDS found in the cDNA is 465 amino acids
in length, and has a calculated molecular weight of
52215.67 Daltons or approximately 52 kD (kiloDaltons).
Amino acid sequence identities with human, chimpan-
zee, rat and mouse sequences ranged from 89-94%
(Figure 2).
Structural and mutational analyses of human GK have
identified residues 78–85, 151, 169, 205, 225–228, 295–
296, 331–333, 336, and 410–416 as important in ATP
binding [8] and residues 151–153, 166–169, 204–206,
225–231, 254–258, 287, and 290 as important for
glucose binding [8,9]. The amino acids involved in ATP-
and glucose-binding in human GK are completely con-
served in feline GK (Figure 2). Amino acid residues (Lys
58, Asn 204, Leu 309, Leu 314, Asn 350, and Leu 355)
previously found to mediate GK binding to its regulatory
protein [10] are also completely conserved in feline pan-
creatic GK (Figure 2). Feline pancreatic GK contains a
leucine-rich 11-aa sequence (300ELVRLVLLKLV310) near
the C-terminus of the protein that is likely to act as a
nuclear export signal (NES) (Figure 2).
Fifteen amino acid residues found in feline GK are not
found in corresponding positions in human, mouse, rat
or chimpanzee GK (Table 1; Figure 3). Of these, 10 are
considered moderately or highly conserved substitutions
and unlikely to affect protein structure or function. The
remaining 5 residues (alanine28, tryptophan35, alanine42,
leucine282, isoleucine426) are non-conserved substitutions.
Three non-conserved residues (alanine27, tryptophan35,
alanine42) are located near the N-terminus and away
from residues involved in ATP or glucose binding and
catalysis. One of the non-conserved residues (leucine282)5’ and 3’ untranslated regions (UTR) are represented by hatched
by gray boxes; the relative size of each box reflects exon length.
tions is shown relative to the assembled cDNA sequence (Genbank
Figure 2 Alignment of feline GCK with other mammalian GCK sequences. *= Identity at this position in all aligned sequences. : = Conserved
substitutions at this position in one or more aligned sequences. . = Semi-conserved substitutions at this position in one or more aligned
sequences <space> = non-identity or nonconserved substitution at this position in one or more aligned sequences.
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Table 1 Conserved and non-conserved amino acid substi-
tutions in feline pancreatic GK
Position Amino acid residue
Feline GK Mammalian GKs‡
16 Ala Val
22 Asp Glu
28 Ala Glu
35 Trp Ser (R) or Arg (P)
42 Ala Asp
219 Arg Gln
239 His Gln
276 Val Met (R) or Leu (P)
280 Asn Ser
282 Leu Ala†
317 Arg His
361 Ala Val (R) or Thr (P)
380 Tyr His
383 Ala Ser
426 Ile Ser
‡Alignments performed using human, chimpanzee, rat, and mouse GKs.
Conserved substitutions are shown in normal text.
Non-conserved substitutions are shown in bold text.
R = rodents (rat and mouse).
P = primates (human and chimpanzee).
†This residue is Ala in rat, human, and chimpanzee; Val in mouse.
Figure 3 Amino acid comparison between fGK and human GK. The loc
proteins are shown. For each position where the sequence differs, the labe
sequence, and the corresponding feline aa. Amino acid residues are shown
human residues in purple.
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(alanine in rat, human and chimpanzee; valine in mouse).
The fifth non-conserved residue (isoleucine426) is found
near the protein C-terminus, where no crucial residues
have been identified. Phylogenic analysis of several mam-
malian GK proteins shows the feline GK protein is closer
to primate GKs than to rodent GKs.
The 465 aa feline GK protein sequence predicted
from pancreatic cDNA is longer than the 450 aa GK
protein (Ensembl Protein ID: ENSFCAP00000013323)
coded by a 1353 bp GK cDNA (Ensembl Transcript ID:
ENSFCAT00000014365) predicted from analysis of feline
genomic DNA. The discrepancy in protein size is due to the
presence of 15 additional amino acids on the N-terminal of
the fGK protein. Direct comparison revealed three amino
acid differences between the two feline GK sequences. The
fGK protein differs from the Ensembl sequence at aa 15
(Lys vs. Gln) and 380 (Tyr vs. His). In addition, Val 99
present in fGK corresponds with a gap in the alignment
with the Ensembl sequence. The predicted size and se-
quence of fGK is more compatible with other mammalian
GK protein sequences than the Ensembl sequence, all of
which are 465 aa in length and contain Lys and Val at the
15 and 91 positions. However, Tyr 380 in fGCK is not found
in other mammalian sequences, which like the Ensembl
feline protein have a His residue at this location.
GK structural model
Homology modeling of the predicted feline GK protein
(Figure 4) demonstrated high structural homology withation of amino acid differences within the feline and human GK
l shows the single letter code for the human aa, the position in the
in stick form with feline residues shown in yellow and corresponding
Figure 4 Homology model of feline pancreatic GK protein. The protein is shown bound to molecules of ATP and glucose with the binding
site and catalytic pocket facing outward. ATP (not shown) binds deeper in the pocket than glucose (shown in green). The residues involved in ATP
binding (dark blue) are completely conserved in the feline GK protein, as are the residues involved in glucose binding (orange). Some residues are
involved in both ATP and glucose binding (pink). Inset – The face of the GK molecule opposite the binding pocket is shown. The N-terminal portion of
the GK molecule (light blue) contains three of the five non-conserved amino acid substitutions found in feline pancreatic GK. Feline GK has trp-arg
(shown in purple and green, respectively) at positions 35 and 36 while other species have arg-arg or ser-arg in these same positions. As a result of the
presence of trp at position 35 and ala at position 28 (another non-conserved feline variant) feline GK lacks a salt bridge that is present in human GK.
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determined by Kamata et al. [11]. Secondary structure
analysis of feline GK reveals the protein has two globular
domains separated by a hinge region (Figure 5). The
cleft formed between the globular regions contains the
residues involved in glucose and ATP binding. The pre-
dicted feline GK structure would permit the globular do-
mains to open and close during substrate binding and is
consistent with a currently proposed mechanistic model
of GK function [12]. The non-conserved amino acid
variants present in feline GK conveyed no appreciable
structural consequences. Three of the non-conserved
residues lie within a N-terminus 43-aa stretch which
forms part of the surface of the GK molecule that is op-
posite the surface that forms the substrate binding cleft
and catalytic region. The feline GK sequence at positions
35 and 36 is trp-arg while other species have arg-arg or
ser-arg in these same positions. As a result of the pres-
ence of trp-35 and ala-28 (another non-conserved feline
variant) feline GK lacks a salt bridge that is present in
human GK [11]. Furthermore, trp-35 is fully solvent
exposed in the model, which may make this portion of
the molecule more lipophilic.
Discussion
The results provide the initial description of the feline
pancreatic GK mRNA and protein, including the complete
nucleotide sequence, amino acid sequence, and molecularstructure. The 2.5 kb feline cDNA contains a 1398 CDS
that has a high nucleotide identity with pancreatic GK
cDNA sequences isolated from other mammals. The fe-
line cDNA encodes a 465 aa protein that has a high degree
of sequence and structural homology with mammalian
pancreatic GK proteins.
The coding region of feline cDNA has a high overall
nucleotide identity with GK mRNAs isolated from pan-
creases of other mammalian species. Percent (%) nucleo-
tide identity is highest with pancreatic GK cDNAs from
primates (>90%) and slightly less with rodent pancreatic
GK cDNAs. The latter finding is consistent with a trend
observed in other feline genes involved in carbohydrate
metabolism, such as G6PC (glucose-6-phosphatase
catalytic subunit) [13] and KHK (ketohexokinase) [14],
which have shown greater nucleotide identity with pri-
mate and canine sequences than with rodent species.
The ten putative exons identified in feline GK have
homology with established exon sequences of human
pancreatic GK. Exon-exon borders in the feline sequence
are identical to those in human GK and feline exons are
similar in length to corresponding human exons. Based
on extensive homology with human exon 1A, which is
expressed in pancreatic endocrine cells but not in hepato-
cytes, exon 1 of feline pancreatic GK can be designated as
exon 1A. GK mRNAs containing alternative exon 1 se-
quences have been isolated from rodent and human tis-
sues [15-17]. Alternatively spliced GK mRNA isoforms are
Figure 5 Secondary structure of feline pancreatic GK showing alpha helices (light coils) and beta sheets (dark arrows). There are two
globular domains separated by a hinge region that allows the globular domains to open and close during substrate binding and release. The
cleft that is formed contains the sites of glucose and ATP binding.
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is present as a single transcript produced via activation of
the neuroendocrine (pancreatic) promoter. Consistent
with findings from other mammals, the feline pancreas
was found to produce a single GK cDNA with homology
to mammalian pancreatic GK and no alternatively spliced
pancreatic isoforms were detected.
Although GK activity has not been demonstrated in
the feline pancreas, pancreatic GK activity is essential
for normal glucose homeostasis in humans and rodents
and a similar role is almost certainly true in cats. Com-
parative analysis of feline GK at the protein level showed
amino acid identities to be slightly higher than at the
nucleotide level but the comparisons followed the same
general pattern across the species examined (Figure 2).
Feline GK has five non-conservative amino acid substi-
tutions that are unique to the feline protein (i.e. these
residues do not appear at the same location in GK from
other mammalian species examined). Non-conserved
amino acid substitutions are of interest because the
introduction of unique amino acids into GK during fe-
line evolution has the potential to impact global protein
function through any of a number of molecular mecha-
nisms, as observed in human GK mutations [18,19].
Among the amino acid residues unique to feline GK, the
most interesting for its possible functional consequences
is Trp35. Unlike the cat, rat, mouse, human, and chim-
panzee all have an Arg residue in this position. Interest-
ingly, an arg→trp mutation at position 36 (adjacent to
the feline substitution) in GCK was detected in a humanpatient with GCK-MODY (also called MODY2), a
monogenetic type of diabetes [20]. In vitro studies that
examined the effects of the R36W mutation on the GK
enzyme found that the kinetic characteristics and ther-
mal stability of the R36W mutant human GK did not
differ from wild type human GK [19]. However, the
R36W mutation is located in a region of the GK protein
that may be important for interaction with GK regulators
and proteins involved in cellular GK localization [19]. The
positively-charged arginine residue at position 35 (arg 35)
forms a salt bridge with glu 28 in human GK but the trp
35 substitution in feline GK abolishes the salt bridge with
glu 28. In addition, trp 35 is fully solvent exposed in the
structural model of feline GK, which would suggest this
region is more lipophilic than the same region on human
GK. Both of these predicted structural changes could
potentially impact feline GK protein dynamics, perhaps by
influencing protein-protein interactions or protein stabil-
ity, as postulated for the R36W mutation of human GK.
When GK is expressed in mammalian liver cells its
cellular localization is determined by its interactions with
GKRP. GKRP is not expressed in pancreatic endocrine
cells but there is evidence that protein interactions are
involved in GK localization in beta cells. The specific
GK residues that mediate binding with GKRP are located
in the small domain and hinge region in the folded protein
and partly overlap with the glucose-binding domain [10].
The amino acids involved in interaction with GKRP are
fully conserved in feline GK but since feline liver does not
express GKRP [6], retention of these residues in the feline
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conservation in the GK protein and the dual role of some
of these residues in GKRP and glucose binding. GK inter-
action with GKRP is needed for entry into the nucleus
[21] but GKRP is not required for GK to exit the nucleus.
Nuclear export signal (NES) sequences enriched in leucine
residues are a characteristic of proteins, like GK, that
can traverse the nuclear membrane. A leucine-rich NES
encompassing positions 300–310 has been defined in
rat GK and similar sequences are found in human,
mouse, and chimpanzee GKs, including conservation of
all lysine residues. In feline GK, the putative NES
sequence is identical to that found in rat GK [21].
Direct determination of cDNA sequences for tran-
scripts expressed in specific tissues can be difficult and
time consuming but the approach has several advantages
over methods that employ gene mining software to iden-
tify putative genes and predict cDNAs from a genomic
DNA template. Direct cDNA sequencing is a particularly
apt method for investigation of the GK gene, which is con-
trolled by multiple promoters and exhibits tissue specific
mRNA expression. The feline cDNA and protein we
report here contain structural and sequence features that
differ from archived feline cDNA and protein sequences
in the Ensembl data base. In particular, the fGK cDNA
and corresponding GK protein sequences we determined
are longer than those determined by primary sequencing
of feline genomic DNA. Comparison of the protein
sequences revealed that the Emsembl protein lacks 15 aa
that are present in the 465 aa fGK predicted from pancre-
atic cDNA. These 15 aa comprise the exon (pancreatic
exon 1) specifically encoded by mRNA produced by
activation of the GK pancreatic promoter. No sequence
corresponding to the pancreatic exon 1 is contained in the
Emsemble cDNA or protein sequences. In human GK, the
pancreatic exon 1 is located near the pancreatic (neuroen-
docrine) promoter, which is far upstream of the remainder
of the coding region (exons 2–10) common to pancreatic
and hepatic GK isoforms. A similar situation is likely to
occur in the feline GK gene since the genomic location of
the 184 nt sequence homologous to the feline GK 5’-UTR
and pancreatic exon 1 is approximately 30 kb upstream of
exon 2. Inability of the predictive software to recognize a
short start sequence so distant from the next exon likely
accounts for the size discrepancy between our reported
cDNA and protein and the Ensembl sequences.
There are few GK sequences from individual cats avail-
able for comparison. Although overall sequence identity
between the fGK cDNA and the putative GK gene con-
tained in the feline genome is very high, several nucleotide
differences were noted. The majority of the differences oc-
curred in the UTR and do not affect protein sequence but
one possible non-synonymous SNP was identified. The
T/C SNP occurs within exon 9 and produces either a Tyr(fGK protein) or a His (Ensembl feline GK protein). The
Tyr at position 380 is unique to feline GK as a His residue
occurs in that position in most mammalian GK sequences
(Figure 2). This was considered a non-synonymous (non-
conserved) difference because Tyr is an uncharged,
aromatic aa and His is a charged aa. Modeling the fGK
protein with Tyr380 had no appreciable effects on the
protein structure but functional studies are required to fully
assess the impact of this possible SNP on the GK protein.
Conclusions
In summary, the pancreatic isoform of feline GK is highly
conserved at the mRNA and protein levels. All residues
crucial for substrate recognition and binding, protein
interactions, and localization are completely conserved in
the feline protein. Several amino acid substitutions unique
to the feline protein were identified but do not signifi-
cantly impact GK structure in the protein model. How-
ever, the impact of each substitution on GK structure and
function was not directly determined. Based on the mo-
lecular analysis performed, it is likely that feline pancreatic
GK functions in a manner similar to other mammalian
pancreatic GK proteins.
Methods
Tissue source
Pancreatic tissue was obtained at necropsy from a non-
diabetic domestic cat that had died of natural causes. Be-
cause no live animals were involved, the studies did not
require approval of the Institutional Animal Care and
Use Committee. All procedures and protocols were in
compliance with institutional guidelines for research
involving biological materials.
Overview of the cloning strategy
A series of primers were designed against conserved re-
gions in published sequences of mammalian GK cDNAs
and used to amplify regions of feline pancreatic cDNA.
The PCR products obtained were sequenced and new
primers designed using feline specific DNA sequences.
A series of primer sets (Table 2) generated a series of
overlapping clones that when assembled comprised the
complete feline GK cDNA.
Reverse transcriptase-PCR (RT-PCR)
Total RNA was isolated from feline pancreas (RNeasy
Micro Kit, Qiagen) and reverse transcribed into cDNA
(Omniscript Reverse Transcription Kit, Qiagen). PCR
was carried out with the Expanded High Fidelity PCR
System (Roche Applied Science) and a TGradient Ther-
mocycler (Biometra) using various primers sets (Table 2)
and feline pancreatic cDNA as the template. Thermal
cycling parameters were 94°C for 5 min, followed by
34 cycles of amplifications at 94°C for 30 s, annealing for
Table 2 Primer sets used in PCR reactions
Primer set Sense Anti-sense
E2-5 5’-GCAGGAGGCCGACTTGAAGA-3’ 5’-CCATCAAACGGAGAGGGGACTT-3’
E5-10 5’-TCGTGGGGCTCCTACGTGAT-3’ 5’-GCACCCCAGCTTCAAGG-3’
E9-10 5’-GCCGCAGCGAGGACGT-3’ 5’-GTGCGCAGGCTGACGCC-3’
3’-RACE 5’-GGGCGTGGACGGCTCTGTGTACAAACTGCA-3’ Provided by kit manufacturer
5’-RACE Provided by kit manufacturer 5’-CCATGACGGGTACTGCTGAG-3’
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elongation step. The annealing temperature used varied
depending on the primers used.
Cloning and sequencing
Gel electrophoresis on a 1% agarose gel was used to
identify PCR products of the correct size. Products were
isolated from the agarose (DNA Gel Extraction Kit,
Millipore Corporation), and ligated into a vector con-
taining the gene for ampicillin resistance (pGEM-T Easy
Vector, Promega). The vector containing the PCR prod-
uct insert was used to transform DH5α cells, which were
spread on agar plates (100 μg/mL ampicillin) and incu-
bated overnight at 37°C. Individual colonies were used
to inoculate 5 mL cultures, which were allowed to incu-
bate overnight at 37°C while shaking. Plasmids were
then isolated (QIAprep Spin Miniprep Kit, Qiagen) from
the DH5α cells. Presence of the insert was determined
by EcoR1 restriction digest, and plasmids containing the
correct insert were sequenced using the T7 promotor
primer at the University of California at Davis Sequen-
cing Facility (ABI 3730 DNA Sequencer).
RACE cloning
Feline-specific primers were designed to be used for
RACE cloning using the GeneRacer Kit with SuperScrip
III Reverse Transcriptase (Invitrogen). Total RNA was
isolated from feline pancreas using the RNeasy Micro
Kit (Qiagen). The cap structure was removed from
mRNAs and the GeneRacer RNA Oligos were ligated
to the 5’ ends. Messenger RNAs were then reverse
transcribed into cDNA using SuperScript III Reverse
Transcriptase and the GeneRace Oligo dT Primer. For
amplification of the 5’ and 3’ ends of the GK cDNA,
PCR was performed with the GeneRacer 5’ and 3’ RACE
kits according to manufacturer’s instructions using spe-
cific 5’ and 3’ end primers provided by the manufacturer
and gene-specific primers designed using the feline GK se-
quence (Table 2). PCR amplification was done by touch-
down PCR using the Expanded High Fidelity PCR System
(Roche Applied Science) and the TGradient Thermocycler
(Biometra).
Gel electrophoresis on a 1% agarose gel was used to
identify products of the correct size. Products were iso-
lated from the agarose (DNA Gel Extraction Kit, MilliporeCorporation), and ligated into the TOPO Cloning Vector
using the TOPO TA Cloning Kit for Sequencing (Invitro-
gen). TOPO vector was used to transform One Shot
TOP10 Chemically Competent Cells (Invitrogen), which
were spread on agar plates (100 μg/mL ampicillin) and
incubated overnight at 37°C. Individual colonies were used
to inoculate 5-mL cultures, which were allowed to incu-
bate overnight at 37°C while shaking. Plasmids were then
isolated (QIAprep Spin Miniprep Kit, Qiagen) from the
One Shot Cells. Presence of the insert was determined by
EcoR1 restriction digest, and plasmids containing the cor-
rect insert were sequenced using the T7 promoter primer
at the University of California at Davis Sequencing Facility
(ABI 3730 DNA Sequencer).
cDNA and protein alignments
The feline cDNA sequence was obtained by aligning
overlapping clones produced by the primer sets using
CLUSTALWa. The feline GK protein sequence was de-
rived by forward translation beginning from an open
reading frame identified at the 3’ end of the assembled
feline GCK cDNA. Comparative alignments of feline
GCK cDNA and protein with sequences obtained from
the respective NCBI databases were made with CLUS-
TALW. Nucleotide sequences used in comparative align-
ment were GenBank accessions human (NM_000162),
chimpanzee (XM_001143661), rat (M25807), mouse
(MN_010292). The protein sequences (with GenBank
accessions) used were: human (NP_000153), chimpanzee
(XP_001143661), rat (EDM00325); mouse (NP_034422).
Molecular modeling
A structural model was generated for the feline glucoki-
nase via homology modeling. To accomplish this, the
target structure was predicted via alignment to a crystal
structure of human GK (PDB ID: 1V4S) [11]. Initial se-
quence alignment for these two systems was performed
with the Clustal-W program [22], using the Blosum 30
substitution matrix, a gap-opening penalty of 10 and a
gap-extension penalty of 0.1. The crystal structure did
not resolve the three residues closest to the N-terminus
and four residues at the C-terminus, but over the
remaining 448 positions, the mutual alignment yielded
95.5% identity and 98.4% similarity, which is indicative
of an excellent template for comparative modeling.
Lindbloom-Hawley et al. BMC Veterinary Research 2014, 10:130 Page 9 of 9
http://www.biomedcentral.com/1746-6148/10/130Based on this alignment and the corresponding three-
dimensional human GK structure, we then predicted
the structure of the analogous feline protein via the
Modeller program [23], using default simulated annea-
ling cycles for structural refinement.
Endnote
ahttp://www.ebi.ac.uk/Tools/msa/clustalw2/(link
accessed 09/24/13).
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